Difference Between Progestin Primed Ovarian Stimulation Protocol and Antagonist Protocol
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20-40
SponsorAssiut University
About this trial
compare the effectiveness and safety of the progestin primed ovarian stimulation (PPOS) protocol versus the antagonist protocol in hyper-responder patients scheduled for a freeze-all policy
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
All normal and poor responder patients according to Olivera equation for overian response peridiction index.
Sever male factor infertility
Trial population
* Eligible patients will be identified and recruited from the IVF Unit at Women's Health Hospital. * Informed consent will be obtained from all participants prior to inclusion in the study.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
270 Participants
are grouped into 2 trial groupsGroup A: Progestin Primed Ovarian Stimulation Protocol group
Group B: Antagonist Protocol group
Trial outcomes
Primary outcomes
1
• Clinical pregnancy rate: The presence of a gestational sac with fetal heartbeat on ultrasound at 7 weeks of gestation. • Live birth rate: The delivery of a live-born infant beyond 24 weeks of gestation
the measure unit is the presence of pulsation in 7-week gestational sac or delivery if fetus beyond 24 weeks as if fetus below 24 w gestation , it's considered abortion
Time frame
1 yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: